Updated:
NOF Corporation
NOF Corporation is a Japanese specialty chemical manufacturer listed on the Tokyo Stock Exchange, serving semiconductors, pharmaceuticals, and energy...
NOF Corporation
NOF Corporation was established in 1941 as Nippon Oils & Fats Co., Ltd., initially focusing on oils and fats. The company rebranded to NOF Corporation in 1992, and today its headquarters remain in Tokyo, Japan. NOF has expanded globally through subsidiaries and offices across Asia, Europe, and North America. NOF's Chemical Products segment produces polyols, functional resins, and energy-related materials used in automotive coatings, construction, and lithium-ion battery binders. Its Life Sciences segment develops active pharmaceutical ingredients (APIs), in-vitro diagnostic reagents, and functional lipids for mRNA vaccine delivery. The company reported consolidated net sales of approximately ¥520 billion (about $3.6 billion) for the fiscal year ended March 2024 and operates 12 manufacturing plants across Japan and abroad. NOF employs roughly 4,600 people worldwide. The company maintains a significant R&D presence, with a central research laboratory in Atsugi, Japan, and collaborates with academic institutions. In July 2023, NOF acquired the U.S.-based specialty chemical manufacturer Polysciences, Inc., expanding its life sciences and functional materials capabilities (per PR Newswire, July 2023). NOF is one of the few Japanese chemical companies with a dedicated life sciences division, reflecting a long-term strategy to diversify beyond commodity chemicals. The company's dual focus on high-margin specialty chemicals and pharmaceutical intermediates provides a structural buffer against cyclical downturns. As a publicly traded entity, NOF's governance follows Japan's Corporate Governance Code, with independent directors comprising one-third of its board.
General information
Firm type
Asset Manager
Year founded
1941
AUM
Undisclosed
Location
Region
Asia
Country
Japan
City
Tokyo
Corporate office
Tokyo, Japan
Additional offices
Osaka, Japan; Nagoya, Japan; Singapore; Bangkok, Thailand; Shanghai, China; Seoul, South Korea; Düsseldorf, Germany; Detroit, USA
Sector focus
Frequently asked questions
What are NOF Corporation's primary business segments?
NOF operates two main segments: Chemical Products, which includes polyols, resins, and energy materials; and Life Sciences, which covers APIs, diagnostic reagents, and functional lipids for drug delivery. The company's revenue mix is roughly 70% chemical products and 30% life sciences (per NOF's FY2023 annual report).
Is NOF Corporation publicly traded?
Yes, NOF Corporation is listed on the Tokyo Stock Exchange under the ticker 4403. As of mid-2025, its market capitalization exceeds $3 billion. The company also has an American Depositary Receipt (ADR) program traded over-the-counter in the US.
What is NOF Corporation's role in the semiconductor industry?
NOF provides thermal management materials, including thermal interface materials and encapsulants, used in semiconductor packaging. Its products support advanced chip manufacturing for smartphones, data centers, and electric vehicles. The company also supplies photoresist-related chemicals for lithography processes.
How did NOF Corporation contribute to COVID-19 vaccines?
NOF is a leading manufacturer of functional lipids used in mRNA vaccine delivery systems. The company supplied key components for COVID-19 vaccines developed by Pfizer/BioNTech and Moderna. NOF has since expanded its lipid production capacity to serve ongoing vaccine and therapeutic RNA needs.
Does NOF Corporation have a presence outside Japan?
Yes, NOF maintains manufacturing facilities in Japan (Aichi, Mie, and others) and operates sales and R&D offices in the United States (Detroit, Michigan), Germany (Düsseldorf), Singapore, Thailand, China, South Korea, and elsewhere. The Polysciences acquisition added manufacturing in Pennsylvania, USA.
What is NOF Corporation's sustainability strategy?
NOF has set a target to achieve carbon neutrality by 2050, with intermediate goals for the 2030s. The company is developing bio-based polyols and environmentally friendly flame retardants. NOF publishes an annual integrated report (since 2020) detailing its ESG performance and progress toward the UN Sustainable Development Goals.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on family offices?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: